Professor Dr
Sherene Loi
FAA
Professor Sherene Loi is a world-leading breast cancer immuno-oncologist. She uncovered the role of resident T cells in the healthy and cancerous breast, transforming our understanding of local tumour surveillance. She has established standardised assays for tumour-infiltrating lymphocytes measurement for breast cancers, now incorporated into national and international pathology guidelines and clinical trial stratification. Her global trial leadership has delivered new strategies for breast cancer treatment into routine clinical care, improving survival for patients worldwide with the implementation of checkpoint and other targeted inhibitors.
Fields of research
32 BIOMEDICAL AND CLINICAL SCIENCES- 3204 IMMUNOLOGY
-
3211
ONCOLOGY AND CARCINOGENESIS
- 321101 Cancer Cell Biology
For full list of research codes, please visit the ARC Website .
Expertise type
- Cancer Immunology
- Cancer Immunotherapy
- Breast Cancer
- Drug Development
- Genomics
Please contact fellowship@science.org.au to request any updates to the data.